001065.KS KSC
JW Pharmaceutical Corporation
1W: +1.6%
1M: +0.2%
3M: +13.4%
YTD: -20.4%
1Y: -23.3%
3Y: -27.0%
5Y: -51.0%
₩22,600.00 ($16.82)
+600.00 (+2.73%)
Weekly Expected Move ±3.3%
₩21086
₩21843
₩22600
₩23357
₩24114
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Smart Money Score
No convergence signal
Key Statistics
Market Cap₩398.7B ($296.8M)
52W Range19710-30300
Volume14
Avg Volume261
Beta0.96
Dividend₩675.00
Analyst Ratings
No analyst coverage
Company Info
CEOYoung-Sub Shin
Employees1,106
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2005-09-29
Websitejw-pharma.co.kr
JW Gwacheon Tower, 38
Gwacheon-si, GY 13840
KR
Gwacheon-si, GY 13840
KR
82 2 840 6777
About JW Pharmaceutical Corporation
Headquartered in Seoul, South Korea, JW Pharmaceutical Corporation is a long-standing entity, established in 1945, specializing in the research, production, and global distribution of a comprehensive range of pharmaceuticals and medical supplies. The company's diverse product portfolio serves markets in Japan and numerous other international regions, addressing a broad spectrum of therapeutic areas including cardiovascular health, gastrointestinal and urinary conditions, central nervous system disorders, infectious diseases, women's health, kidney ailments, respiratory issues, oncology, pain management, and critical care nutrition.
Latest News
No recent news
Recent Insider Trades
No insider trades found